These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 17944563

  • 1. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.
    Zhang D, Fan D.
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1369-78. PubMed ID: 17944563
    [Abstract] [Full Text] [Related]

  • 2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K.
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [Abstract] [Full Text] [Related]

  • 3. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K.
    Hepatogastroenterology; 2008 May; 55(86-87):1530-6. PubMed ID: 19102336
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
    Stege A, Priebsch A, Nieth C, Lage H.
    Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence.
    Sawicka M, Kalinowska M, Skierski J, Lewandowski W.
    J Pharm Pharmacol; 2004 Sep; 56(9):1067-81. PubMed ID: 15324475
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.
    Boumendjel A, Baubichon-Cortay H, Trompier D, Perrotton T, Di Pietro A.
    Med Res Rev; 2005 Jul 21; 25(4):453-72. PubMed ID: 15834856
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recent advances in the research of P-glycoprotein inhibitors.
    Yang K, Wu J, Li X.
    Biosci Trends; 2008 Aug 21; 2(4):137-46. PubMed ID: 20103919
    [Abstract] [Full Text] [Related]

  • 14. Multidrug-resistant hela cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide.
    Souslova T, Averill-Bates DA.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1538-51. PubMed ID: 15590186
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
    Li X, Hong L, Zhao Y, Jin H, Fan R, Du R, Xia L, Luo G, Fan D.
    Biochem Cell Biol; 2007 Dec 01; 85(6):741-50. PubMed ID: 18059532
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multidrug resistance in hematological malignancy.
    Hirose M, Hosoi E, Hamano S, Jalili A.
    J Med Invest; 2003 Aug 01; 50(3-4):126-35. PubMed ID: 13678381
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
    Schmidt M, Teitge M, Castillo ME, Brandt T, Dobner B, Langner A.
    Arch Pharm (Weinheim); 2008 Oct 01; 341(10):624-38. PubMed ID: 18816589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.